Wednesday, August 26, 2015

News: Conventus Orthopaedics Announces First Surgeries for Conventus PH Cage™, Proximal Humerus Implant Device in United States and Europe

The Early Surgical Cases of the Conventus PH Cage™, the Industry's First Alternative to Traditional Treatment Options for Proximal Humeral (Shoulder) Fractures, Demonstrate a Simpler Surgical Procedure That Could Improve Patient Outcomes
Conventus Orthopaedics, Inc.
MINNEAPOLIS, MN--(Marketwired - August 26, 2015) - With the recent initial surgeries of the Conventus PH Cage™ patients and their surgeons have begun benefitting from the industry's first self-expanding fracture cage.

Utilizing the shape memory properties of nitinol, the Conventus Cage™ System expands within the bone creating robust fixation and preventing further collapse of the fracture while eliminating the need for allograft. Similar to the company's first DRS™ product for the wrist, the new Conventus PH™ Cage implant creates a rigid internal scaffold upon completion of the implant procedure.
With the shoulder's range of motion and unique forces, physicians have long awaited a less invasive and more stable surgical approach over current technologies. Prior to the introduction of the Conventus PH Cage™, patients with multipart fractures of the proximal humerus requiring surgical treatment were limited to traditional fixation technologies or in some cases left to consider shoulder replacement alternatives.
"We are very excited to have successfully completed the first U.S. Conventus PH Cage™ procedures with Dr. Paul Paterson (Buffalo, NY) and Dr. Edwin E. Spencer, Jr. (Knoxville, TN), in addition to our first German Conventus PH Cage™ procedures with Dr. med. Michael Jonas in Moers, Germany. This innovative three dimensional fracture management technology was originally developed with proximal humerus fractures in mind, based upon the ability to achieve reliable 3D fixation in a less invasive manner. This is a major step in our journey to create a broad fracture fixation technology platform," said Paul Buckman, Conventus Orthopaedics CEO.
The company is in the process of a measured U.S. market introduction.
Conventus designed and developed the proprietary device in close consultation with an expert group of surgeon advisors. The design is aligned with the principles of the Conventus platform technology, which emphasize preservation of tissues and blood supply at the fracture site, creating a strong foundation by stabilizing bone fragments and facilitating early motion through less invasive procedures.
"The Conventus PH Cage's less invasive approach and versatility enables secure fixation within the proximal humerus where familiar techniques of open reduction, internal fixation and arthroplasty still have been shown to have limitations for proximal humerus repair," said Paul Paterson, M.D. Edwin E. Spencer, Jr., M.D. added, "The Conventus PH Cage provides intramedullary fragment support, which allows flexible fixation to stabilize even osteoporotic bone fragments. Those aspects make Conventus PH Cage a game-changer. The cage's ability to resist fracture collapse should lead to fewer complications and facilitate surgeon confidence in addressing even challenging repairs resulting in better outcomes that can be demonstrated as we build clinical experience."
The cleared intended use for the device, "The Conventus Orthopaedics PH Cage™ is indicated for the fixation of proximal humerus fractures except when there are too many fracture fragments to repair the articular surface." For more information regarding use of the device please refer to
About Conventus Orthopaedics, Inc.
Conventus Orthopaedics, Inc. was founded by a team of medical device professionals and physicians with the sole purpose of improving patient care by creating a platform technology with less invasive solutions to a broad range of challenging peri-articular fractures. Taking its name from the Latin word for coming together or union, Conventus Orthopaedics is focused on creating less invasive solutions for fractures in and around the joints. The company is dedicated to working with surgeons to improve healing and enable their patients' return to normal activities.


No comments:

Post a Comment